The Evolution of Anti-Obesity Drugs and Market Rivalry

This chapter examines the transformation of a pharmaceutical company from a dependable insulin provider to a leader in innovative diabetes and weight loss drugs like Ozempic and Wegovy. It highlights the competitive dynamics between major players in the market, particularly focusing on the rivalry with Eli Lilly and the historical context of their insulin-producing legacy.